Kennedy Capital Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Kennedy Capital Management’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-60,847	Closed	-$1.92M	–	775
2015 Q3	$1.92M	Sell	60,847 -18,727	-24%	-$896K	0.04%	577
2015 Q2	$4.71M	Sell	79,574 -87,241	-52%	-$6.15M	0.08%	411
2015 Q1	$17.8M	Buy	166,815 +3,490	+2%	+$333K	0.31%	74
2014 Q4	$15.3M	Buy	163,325 +98,470	+152%	+$9.39M	0.28%	84
2014 Q3	$4.98M	Buy	64,855 +31,616	+95%	+$2.49M	0.1%	372
2014 Q2	$2.98M	Buy	+33,239	New	+$2.04M	0.06%	471

Other funds holding PTX

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Kennedy Capital Management's PTX Position: Q4 2015 in Review

Kennedy Capital Management sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q4 2015, closing a stake of 60,847 shares — an estimated $1.92M sold.

Kennedy Capital Management first reported a position in PTX in Q2 2014 and held it in 6 quarters. The position peaked at $17.8M in Q1 2015. 101 funds tracked by Wall St. Rank hold PTX as of Q4 2015.

Kennedy Capital Management reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q4 2015 after selling out during the quarter.
Kennedy Capital Management sold 60,847 Pernix Therapeutics Holdings, Inc. shares in Q4 2015, an estimated $1.92M.
Kennedy Capital Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and held it in 6 quarters.
Kennedy Capital Management's Pernix Therapeutics Holdings, Inc. position peaked at $17.8M in Q1 2015.
101 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q4 2015.

Based on Kennedy Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.